NPI: 1689653305 · ROYAL OAK, MI 48073 · General Acute Care Hospital · NPI assigned 01/11/2006
Authorized official COX, MATTHEW controls 20+ related entities in our dataset. Read more
| Authorized Official | COX, MATTHEW (CHIEF FINANCIAL OFFICER) |
| NPI Enumeration Date | 01/11/2006 |
Other providers sharing the same authorized official: COX, MATTHEW
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 462,188 | $17.11M |
| 2019 | 704,571 | $17.40M |
| 2020 | 650,723 | $17.92M |
| 2021 | 1,049,860 | $25.88M |
| 2022 | 1,098,412 | $30.28M |
| 2023 | 1,177,167 | $29.84M |
| 2024 | 1,080,499 | $24.21M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 93,572 | 86,610 | $40.93M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 248,995 | 223,400 | $16.98M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 42,860 | 41,503 | $8.79M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 30,917 | 29,701 | $4.17M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 43,290 | 40,611 | $3.52M |
| 80061 | Lipid panel | 195,525 | 194,803 | $2.48M |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 138,326 | 137,825 | $2.37M |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 11,333 | 11,281 | $2.19M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 53,893 | 16,085 | $2.15M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 83,291 | 23,994 | $1.98M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 92,684 | 90,885 | $1.89M |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 709 | 707 | $1.88M |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 90,686 | 88,899 | $1.84M |
| 84443 | Thyroid stimulating hormone (TSH) | 186,587 | 184,900 | $1.84M |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 39,714 | 38,159 | $1.82M |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 7,054 | 6,956 | $1.61M |
| 80053 | Comprehensive metabolic panel | 294,975 | 278,595 | $1.56M |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 36,080 | 13,870 | $1.42M |
| 82947 | 40,182 | 28,454 | $1.32M | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 11,731 | 11,534 | $1.26M |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 2,635 | 2,608 | $1.25M |
| 96361 | Intravenous infusion, hydration; each additional hour | 30,061 | 24,283 | $1.17M |
| 71046 | Radiologic examination, chest; 2 views | 27,394 | 26,597 | $1.12M |
| G0378 | Hospital observation service, per hour | 28,475 | 25,166 | $1.10M |
| 93975 | 10,192 | 9,823 | $1.07M | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 312,370 | 288,753 | $1.05M |
| 78815 | Positron emission tomography (PET) for limited area imaging | 1,517 | 1,488 | $1.04M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 12,113 | 11,497 | $944K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 4,900 | 4,842 | $939K |
| 83036 | Hemoglobin; glycosylated (A1C) | 158,604 | 157,900 | $904K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 38,650 | 12,250 | $887K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2,828 | 2,804 | $886K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 13,769 | 13,085 | $880K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 8,964 | 8,667 | $825K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,720 | 1,707 | $817K |
| 82607 | 88,037 | 87,629 | $765K | |
| 70450 | Computed tomography, head or brain; without contrast material | 11,412 | 11,137 | $732K |
| 59025 | Fetal non-stress test | 8,698 | 5,589 | $721K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 48,970 | 48,722 | $670K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 42,271 | 12,625 | $665K |
| 96375 | Therapeutic injection; each additional sequential IV push | 33,983 | 28,238 | $662K |
| 20610 | 4,538 | 4,385 | $656K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 13,573 | 13,537 | $636K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 29,035 | 28,522 | $616K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 8,064 | 7,898 | $598K |
| 80074 | 21,009 | 20,829 | $593K | |
| 62323 | 1,929 | 1,911 | $580K | |
| 41899 | Unlisted procedure, dentoalveolar structures | 402 | 402 | $571K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 24,606 | 24,123 | $504K |
| 71045 | Radiologic examination, chest; single view | 15,343 | 14,632 | $495K |
| 76770 | 8,419 | 8,306 | $482K | |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 557 | 465 | $476K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 10,377 | 9,483 | $463K |
| 76830 | Ultrasound, transvaginal | 8,387 | 8,279 | $458K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 3,434 | 3,401 | $444K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 9,880 | 9,749 | $442K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 8,270 | 7,991 | $421K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 6,955 | 6,938 | $415K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 102,053 | 98,607 | $413K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 26,061 | 26,040 | $409K |
| 87480 | 34,348 | 33,583 | $408K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 24,703 | 23,813 | $403K |
| 74183 | 2,154 | 2,140 | $402K | |
| 82728 | 52,140 | 51,481 | $402K | |
| 87660 | 33,809 | 33,053 | $397K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 18,056 | 18,032 | $376K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4,386 | 4,307 | $376K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 21,383 | 20,384 | $371K |
| 87510 | 31,981 | 31,274 | $368K | |
| 36430 | 2,468 | 1,877 | $366K | |
| 97162 | 7,744 | 7,608 | $366K | |
| 84466 | 49,219 | 48,743 | $362K | |
| 76801 | 6,407 | 5,921 | $361K | |
| 93350 | 1,505 | 1,494 | $356K | |
| 86003 | 5,467 | 5,347 | $343K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 18,311 | 16,137 | $340K |
| 84439 | 60,855 | 60,256 | $325K | |
| 77334 | 918 | 714 | $323K | |
| 92587 | 2,372 | 2,352 | $323K | |
| 83013 | 7,560 | 7,541 | $321K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 4,957 | 4,943 | $313K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 2,995 | 2,979 | $312K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | 1,139 | 1,122 | $297K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 1,839 | 1,435 | $297K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 167 | 157 | $290K |
| 84481 | 27,165 | 26,960 | $288K | |
| 76819 | Fetal biophysical profile; without non-stress testing | 4,880 | 2,364 | $288K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3,833 | 3,724 | $283K |
| 92523 | 2,675 | 2,648 | $277K | |
| 93970 | 3,131 | 3,100 | $271K | |
| 86803 | 29,943 | 29,835 | $270K | |
| 86900 | 24,049 | 22,431 | $254K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 3,608 | 3,542 | $249K |
| 82746 | 30,481 | 30,279 | $248K | |
| 87631 | 14,796 | 14,565 | $245K | |
| 97116 | 15,754 | 6,827 | $240K | |
| 90670 | 4,505 | 4,497 | $239K | |
| 77066 | Tomosynthesis, mammo | 4,278 | 4,208 | $237K |
| 95700 | 1,304 | 1,295 | $232K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 1,849 | 1,831 | $232K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 23,162 | 22,809 | $228K |
| 76825 | 827 | 790 | $221K | |
| 36415 | Collection of venous blood by venipuncture | 151,009 | 131,052 | $216K |
| 58558 | 178 | 175 | $210K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 2,780 | 2,772 | $210K |
| 76642 | 5,422 | 5,382 | $209K | |
| 20680 | 210 | 202 | $206K | |
| 54161 | 647 | 645 | $202K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 1,309 | 930 | $199K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 258 | 252 | $197K |
| 97161 | 3,785 | 3,735 | $196K | |
| 83540 | 51,951 | 51,449 | $195K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 82,454 | 69,707 | $191K |
| 19083 | 253 | 250 | $190K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 436 | 432 | $189K |
| 85027 | 87,995 | 78,461 | $186K | |
| 76536 | 3,797 | 3,784 | $184K | |
| 86780 | 20,688 | 20,522 | $179K | |
| 93458 | 132 | 132 | $176K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 848 | 846 | $172K |
| 93971 | 3,631 | 3,520 | $171K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | 1,630 | 1,350 | $171K |
| 84403 | 10,715 | 10,616 | $170K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 7,735 | 5,099 | $170K |
| 94060 | 1,233 | 1,229 | $168K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 1,428 | 1,425 | $167K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 9,940 | 9,874 | $166K |
| 93017 | 5,801 | 5,742 | $164K | |
| 77065 | Tomosynthesis, mammo | 3,884 | 3,610 | $163K |
| 47562 | 49 | 49 | $162K | |
| 84702 | 56,534 | 51,619 | $162K | |
| 86769 | 6,687 | 6,651 | $161K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 3,326 | 3,191 | $154K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 5,656 | 5,522 | $154K |
| 27447 | 28 | 28 | $153K | |
| G0379 | Direct admission of patient for hospital observation care | 195 | 188 | $151K |
| 72141 | 1,424 | 1,417 | $146K | |
| 77336 | 2,302 | 1,032 | $146K | |
| 44970 | 49 | 49 | $146K | |
| C8921 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, for congenital cardiac anomalies; complete | 420 | 408 | $144K |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 11,654 | 11,643 | $144K |
| 83735 | 53,021 | 46,539 | $142K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 400 | 398 | $142K |
| 27130 | 24 | 24 | $141K | |
| 87070 | 29,323 | 28,751 | $138K | |
| 49083 | 340 | 165 | $138K | |
| 97166 | 2,838 | 2,782 | $135K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 166 | 158 | $133K |
| 97165 | 2,376 | 2,351 | $132K | |
| 95816 | 1,131 | 1,128 | $128K | |
| 83970 | 5,841 | 5,741 | $125K | |
| 58661 | 41 | 41 | $123K | |
| 71250 | 2,382 | 2,369 | $120K | |
| 87077 | 23,816 | 23,297 | $111K | |
| 87632 | 2,159 | 2,132 | $111K | |
| 87653 | 6,564 | 6,513 | $111K | |
| 87186 | 23,813 | 23,292 | $111K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 6,571 | 5,655 | $111K |
| 75574 | 1,937 | 1,927 | $109K | |
| 97535 | Self-care/home management training, each 15 minutes | 7,698 | 5,177 | $109K |
| 86696 | 9,669 | 9,603 | $109K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 65,371 | 59,214 | $106K |
| 73221 | 807 | 803 | $103K | |
| 93308 | 1,219 | 1,154 | $100K | |
| 86038 | 14,229 | 14,134 | $99K | |
| 70491 | 994 | 981 | $98K | |
| 84550 | 35,883 | 35,150 | $98K | |
| 88184 | 1,710 | 1,670 | $97K | |
| 77080 | 1,718 | 1,715 | $95K | |
| 93880 | 1,569 | 1,561 | $94K | |
| 72197 | 551 | 545 | $91K | |
| 82670 | 5,434 | 5,394 | $90K | |
| 83001 | 8,026 | 7,989 | $89K | |
| 93798 | 1,673 | 348 | $89K | |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | 5,507 | 5,489 | $87K |
| 84153 | 8,313 | 8,270 | $83K | |
| 95951 | 221 | 153 | $80K | |
| 87340 | 15,118 | 15,012 | $79K | |
| 82043 | 22,959 | 22,850 | $79K | |
| 87147 | 15,876 | 15,533 | $77K | |
| 83880 | 9,199 | 8,789 | $76K | |
| 84146 | 6,524 | 6,470 | $75K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 1,487 | 1,474 | $75K |
| 86695 | 9,670 | 9,603 | $74K | |
| 87529 | 3,247 | 3,212 | $74K | |
| 72110 | 4,168 | 4,129 | $74K | |
| 86480 | 2,448 | 2,436 | $73K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 13,949 | 13,432 | $72K |
| 70486 | 1,878 | 1,865 | $72K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 16,425 | 9,158 | $71K |
| 77300 | 462 | 424 | $71K | |
| 83002 | 6,392 | 6,362 | $70K | |
| 76881 | 1,220 | 1,207 | $70K | |
| 94726 | 1,405 | 1,403 | $69K | |
| 95716 | 183 | 140 | $68K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 19,233 | 12,710 | $67K |
| 82784 | 8,255 | 8,085 | $67K | |
| 86235 | 2,614 | 2,491 | $66K | |
| 90686 | 5,470 | 5,445 | $66K | |
| 81003 | 73,735 | 70,825 | $65K | |
| 73560 | 7,380 | 7,111 | $65K | |
| 87634 | 1,553 | 1,540 | $65K | |
| 73564 | 4,133 | 4,044 | $62K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 2,345 | 2,305 | $62K |
| 97163 | 1,379 | 1,373 | $61K | |
| 87522 | Neg quan hep c or qual rna | 2,613 | 2,552 | $60K |
| 83021 | 5,822 | 5,795 | $59K | |
| 84402 | 4,142 | 4,119 | $59K | |
| 70544 | 457 | 452 | $58K | |
| 75561 | 296 | 296 | $58K | |
| 86140 | 25,770 | 24,135 | $58K | |
| 74019 | 4,015 | 3,936 | $57K | |
| 82785 | 6,086 | 5,781 | $57K | |
| 81001 | 51,959 | 49,487 | $57K | |
| 73030 | 6,361 | 6,147 | $56K | |
| 73502 | 4,495 | 4,361 | $55K | |
| 90651 | 649 | 645 | $55K | |
| 73610 | 5,958 | 5,632 | $54K | |
| 31231 | 610 | 593 | $54K | |
| 74018 | 3,242 | 2,992 | $53K | |
| 29888 | 12 | 12 | $51K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 4,190 | 4,190 | $51K |
| 83655 | 6,982 | 6,937 | $49K | |
| 86762 | 6,615 | 6,577 | $48K | |
| 81514 | 264 | 264 | $48K | |
| 84478 | 2,112 | 1,793 | $47K | |
| 83690 | 34,957 | 32,971 | $47K | |
| 76882 | 1,407 | 1,375 | $47K | |
| 80076 | 15,142 | 14,333 | $47K | |
| 86592 | 15,743 | 15,644 | $47K | |
| 88185 | 715 | 653 | $46K | |
| 86376 | 5,145 | 5,122 | $45K | |
| 71271 | 827 | 827 | $44K | |
| 82627 | 3,277 | 3,269 | $44K | |
| 82248 | 23,561 | 21,228 | $44K | |
| 82550 | 15,896 | 15,015 | $44K | |
| 84144 | 3,418 | 3,303 | $43K | |
| 87536 | 1,059 | 1,053 | $43K | |
| 84450 | 16,365 | 15,885 | $43K | |
| 72100 | 3,293 | 3,217 | $43K | |
| 86147 | 1,129 | 1,102 | $42K | |
| 84460 | 14,977 | 14,444 | $42K | |
| 73110 | 4,643 | 4,335 | $42K | |
| 10005 | 126 | 126 | $41K | |
| 19081 | 50 | 50 | $41K | |
| 82565 | 16,003 | 15,121 | $41K | |
| 85610 | 29,687 | 24,102 | $41K | |
| 86787 | 5,874 | 5,814 | $40K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | 3,537 | 3,481 | $40K |
| 73130 | 5,231 | 4,953 | $40K | |
| 93225 | 1,168 | 1,164 | $39K | |
| 80051 | 9,765 | 9,444 | $39K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 56 | 56 | $39K |
| 86706 | 6,583 | 6,539 | $39K | |
| 82105 | 4,317 | 4,242 | $39K | |
| 82570 | 16,002 | 15,392 | $39K | |
| 82652 | 1,771 | 1,764 | $38K | |
| 86665 | 2,463 | 2,362 | $38K | |
| 96367 | 2,391 | 2,062 | $38K | |
| 72156 | 272 | 271 | $37K | |
| 73630 | 5,413 | 5,236 | $37K | |
| 85652 | 28,157 | 27,023 | $36K | |
| 86850 | 23,163 | 21,542 | $36K | |
| 93296 | 2,136 | 2,127 | $36K | |
| 73523 | 685 | 680 | $36K | |
| 80069 | 10,115 | 8,704 | $35K | |
| 73700 | 598 | 586 | $34K | |
| 92586 | 468 | 468 | $33K | |
| 83516 | 5,339 | 5,222 | $33K | |
| 82274 | 3,520 | 3,506 | $33K | |
| 88112 | 2,125 | 2,092 | $33K | |
| 62321 | 106 | 105 | $32K | |
| 72040 | 2,554 | 2,443 | $31K | |
| 84425 | 2,501 | 2,487 | $30K | |
| 82533 | 3,122 | 3,020 | $30K | |
| 86200 | 3,965 | 3,953 | $30K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 436 | 398 | $30K |
| 84520 | 14,383 | 13,644 | $30K | |
| 74178 | 209 | 207 | $30K | |
| 86800 | 3,224 | 3,186 | $29K | |
| 86870 | 371 | 357 | $29K | |
| 80081 | 781 | 780 | $29K | |
| 73590 | 4,178 | 4,024 | $29K | |
| 86160 | 2,311 | 2,251 | $29K | |
| 31575 | 387 | 384 | $27K | |
| C8929 | Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography | 135 | 135 | $27K |
| 77295 | 43 | 42 | $27K | |
| 84100 | 15,284 | 12,838 | $27K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 3,039 | 2,973 | $26K |
| 86431 | 7,853 | 7,821 | $26K | |
| 74022 | 3,136 | 3,066 | $26K | |
| 88142 | 2,042 | 2,038 | $25K | |
| 82378 | 2,380 | 2,200 | $25K | |
| 72158 | 306 | 303 | $24K | |
| 73140 | 2,009 | 1,826 | $24K | |
| 82150 | 7,526 | 7,397 | $24K | |
| 86146 | 878 | 860 | $24K | |
| 10060 | 311 | 303 | $23K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 68 | 66 | $23K |
| 88342 | 2,632 | 2,547 | $23K | |
| 86141 | 2,860 | 2,824 | $23K | |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 67 | 66 | $23K |
| 72070 | 1,651 | 1,635 | $22K | |
| 52332 | 27 | 26 | $22K | |
| 90732 | 257 | 256 | $22K | |
| 92610 | 914 | 903 | $22K | |
| 86225 | 2,900 | 2,860 | $22K | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 316 | 316 | $22K |
| 86704 | 3,450 | 3,428 | $21K | |
| 90474 | 3,785 | 3,781 | $21K | |
| 86828 | 647 | 637 | $21K | |
| G0475 | Hiv antigen/antibody, combination assay, screening | 1,702 | 1,695 | $21K |
| 84134 | 2,902 | 2,670 | $21K | |
| 84445 | 689 | 686 | $21K | |
| 73080 | 2,683 | 2,565 | $21K | |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 80 | 50 | $20K |
| 80197 | 2,891 | 1,725 | $20K | |
| 85730 | 15,812 | 14,720 | $20K | |
| 94010 | 1,085 | 1,079 | $20K | |
| 88307 | 1,832 | 1,777 | $19K | |
| 73090 | 3,371 | 3,132 | $19K | |
| 76870 | 1,646 | 1,622 | $19K | |
| 80050 | General health panel | 1,312 | 1,312 | $19K |
| 54300 | 12 | 12 | $19K | |
| 92579 | 1,605 | 1,598 | $19K | |
| 84165 | 3,251 | 3,192 | $19K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 7,406 | 6,711 | $19K |
| 86360 | 944 | 930 | $19K | |
| 42830 | 14 | 14 | $18K | |
| 25605 | 24 | 24 | $18K | |
| 82247 | 7,462 | 6,058 | $18K | |
| 20605 | 134 | 132 | $18K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 805 | 790 | $18K |
| 86039 | 2,731 | 2,710 | $17K | |
| 87427 | 2,102 | 2,037 | $17K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 251 | 250 | $17K |
| 95909 | 118 | 118 | $17K | |
| 83615 | 5,907 | 5,331 | $17K | |
| 92557 | 533 | 531 | $17K | |
| 87517 | 700 | 672 | $17K | |
| 87205 | 9,373 | 9,126 | $17K | |
| 95953 | 92 | 78 | $17K | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 237 | 237 | $16K |
| 87046 | 2,239 | 2,168 | $15K | |
| 90677 | 233 | 233 | $15K | |
| 86256 | 1,766 | 1,738 | $15K | |
| 76000 | 635 | 618 | $15K | |
| 92083 | 814 | 802 | $15K | |
| 86359 | 946 | 932 | $15K | |
| 73060 | 2,306 | 2,210 | $15K | |
| 83525 | 2,093 | 2,083 | $15K | |
| 82950 | 5,675 | 5,629 | $15K | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 213 | 213 | $15K |
| 85046 | 6,055 | 5,547 | $14K | |
| 67028 | Intravitreal injection of a pharmacologic agent | 107 | 92 | $14K |
| 72170 | 866 | 855 | $14K | |
| 86304 | 1,210 | 1,145 | $14K | |
| 90716 | 628 | 628 | $14K | |
| 92526 | 396 | 192 | $14K | |
| 83090 | 1,445 | 1,436 | $14K | |
| 86664 | 2,015 | 1,996 | $14K | |
| 86334 | 1,094 | 1,077 | $14K | |
| 77290 | 82 | 75 | $13K | |
| 82310 | 4,148 | 4,103 | $13K | |
| 84156 | 8,581 | 7,936 | $13K | |
| 73552 | 2,333 | 2,247 | $13K | |
| 87428 | 425 | 420 | $13K | |
| 90750 | 92 | 92 | $12K | |
| 86301 | 1,118 | 1,084 | $12K | |
| 84484 | 35,548 | 29,031 | $12K | |
| C8908 | Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral | 63 | 63 | $12K |
| 84630 | 1,763 | 1,758 | $12K | |
| 86663 | 2,022 | 2,001 | $12K | |
| 91200 | 179 | 179 | $11K | |
| 88341 | 1,390 | 1,311 | $11K | |
| 72082 | 340 | 338 | $11K | |
| 73070 | 1,430 | 1,284 | $11K | |
| 90734 | 335 | 333 | $11K | |
| 81025 | 9,608 | 9,447 | $11K | |
| 86255 | 1,641 | 1,589 | $11K | |
| 82977 | 3,053 | 2,917 | $11K | |
| 85379 | 6,820 | 6,660 | $11K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 24,820 | 23,973 | $11K |
| 74174 | 81 | 81 | $11K | |
| 74230 | 185 | 182 | $11K | |
| 83993 | 1,125 | 1,114 | $11K | |
| 72146 | 130 | 129 | $11K | |
| 82465 | 4,260 | 4,159 | $10K | |
| 93923 | 165 | 164 | $10K | |
| 82088 | 462 | 458 | $10K | |
| 93299 | 660 | 649 | $10K | |
| 82525 | 1,391 | 1,388 | $10K | |
| 73562 | 613 | 590 | $10K | |
| 95708 | 50 | 48 | $10K | |
| 95910 | 77 | 77 | $10K | |
| 86765 | 1,301 | 1,286 | $10K | |
| 86901 | 22,667 | 21,153 | $10K | |
| 83010 | 1,427 | 1,404 | $10K | |
| 93270 | 736 | 733 | $10K | |
| 88121 | 55 | 55 | $9K | |
| 76506 | 188 | 186 | $9K | |
| 52000 | 40 | 38 | $9K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 5,740 | 5,679 | $9K |
| 87075 | 2,959 | 2,877 | $9K | |
| 84432 | 885 | 879 | $9K | |
| 95819 | 110 | 110 | $9K | |
| 76885 | 238 | 236 | $9K | |
| 86833 | 94 | 92 | $9K | |
| 86832 | 94 | 92 | $9K | |
| 87338 | 1,173 | 1,169 | $9K | |
| 88304 | 2,444 | 2,408 | $9K | |
| 86735 | 1,051 | 1,041 | $9K | |
| 10022 | 32 | 28 | $9K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 393 | 386 | $8K |
| 82270 | 117 | 114 | $8K | |
| 29881 | 12 | 12 | $8K | |
| 82040 | 3,756 | 3,535 | $8K | |
| 77072 | 231 | 231 | $8K | |
| 84075 | 2,863 | 2,788 | $8K | |
| 80164 | 1,604 | 1,488 | $8K | |
| 86708 | 1,306 | 1,292 | $8K | |
| 82103 | 953 | 943 | $8K | |
| 96376 | 20,146 | 11,746 | $8K | |
| 80177 | 1,517 | 1,447 | $7K | |
| 87045 | 2,197 | 2,168 | $7K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 4,159 | 4,038 | $7K |
| 70487 | 89 | 86 | $7K | |
| 82330 | 2,057 | 1,951 | $7K | |
| 90744 | 909 | 908 | $7K | |
| 76641 | 122 | 121 | $6K | |
| 71101 | 411 | 409 | $6K | |
| 87081 | 1,938 | 1,917 | $6K | |
| 43235 | 16 | 16 | $6K | |
| 82805 | 2,479 | 2,322 | $6K | |
| 77470 | 37 | 36 | $6K | |
| 84305 | 534 | 532 | $6K | |
| 83921 | 509 | 505 | $6K | |
| 87209 | 964 | 942 | $6K | |
| 74455 | 54 | 53 | $6K | |
| 73100 | 1,006 | 927 | $6K | |
| 87449 | 1,738 | 1,702 | $6K | |
| G2066 | Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results | 319 | 313 | $6K |
| 86923 | 1,325 | 1,123 | $6K | |
| 92134 | 2,032 | 1,913 | $5K | |
| 87324 | 1,564 | 1,545 | $5K | |
| 92611 | 119 | 119 | $5K | |
| 84155 | 2,831 | 2,667 | $5K | |
| 87102 | 1,446 | 1,422 | $5K | |
| 86644 | 711 | 709 | $5K | |
| 73000 | 480 | 444 | $5K | |
| 20600 | 30 | 30 | $5K | |
| 93351 | 19 | 19 | $5K | |
| 72050 | 134 | 134 | $5K | |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | 350 | 350 | $5K |
| 92235 | 56 | 53 | $5K | |
| 82985 | 396 | 395 | $5K | |
| 87641 | 472 | 460 | $5K | |
| 90671 | 324 | 324 | $5K | |
| 87328 | 698 | 691 | $5K | |
| 81002 | 4,533 | 4,317 | $5K | |
| 82390 | 756 | 749 | $5K | |
| 45384 | 12 | 12 | $5K | |
| 82951 | 581 | 574 | $4K | |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | 16 | 13 | $4K |
| 82671 | 213 | 213 | $4K | |
| 76820 | 2,733 | 1,348 | $4K | |
| 87329 | 732 | 726 | $4K | |
| 99496 | 67 | 67 | $4K | |
| 83721 | 671 | 669 | $4K | |
| 70360 | 287 | 284 | $4K | |
| 88313 | 392 | 365 | $4K | |
| 84132 | 3,311 | 3,207 | $4K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 61 | 61 | $4K |
| 83521 | 230 | 208 | $4K | |
| 82024 | 194 | 189 | $4K | |
| 82157 | 283 | 279 | $4K | |
| 62270 | 13 | 13 | $4K | |
| 86364 | 637 | 633 | $4K | |
| 87640 | 421 | 408 | $4K | |
| 93246 | 228 | 228 | $4K | |
| 90688 | 216 | 214 | $4K | |
| 89051 | 2,389 | 2,132 | $4K | |
| 62328 | 12 | 12 | $4K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 136 | 136 | $4K |
| 86352 | 52 | 52 | $4K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | 89 | 88 | $3K |
| 86618 | 437 | 429 | $3K | |
| 82962 | 8,524 | 6,787 | $3K | |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | 154 | 152 | $3K |
| 36416 | 1,315 | 1,074 | $3K | |
| 90656 | 375 | 373 | $3K | |
| 64450 | 110 | 108 | $3K | |
| 51798 | 1,031 | 1,014 | $3K | |
| 87177 | 965 | 942 | $3K | |
| 87535 | 136 | 136 | $3K | |
| 83550 | 800 | 792 | $3K | |
| 82677 | 244 | 244 | $3K | |
| 92133 | 573 | 563 | $3K | |
| 70498 | 118 | 118 | $3K | |
| 85055 | 193 | 130 | $3K | |
| 97014 | 340 | 113 | $2K | |
| 77280 | 41 | 39 | $2K | |
| 72052 | 55 | 55 | $2K | |
| 99381 | 35 | 35 | $2K | |
| 84244 | 186 | 185 | $2K | |
| 81372 | 12 | 12 | $2K | |
| 83704 | 131 | 131 | $2K | |
| 90480 | 69 | 69 | $2K | |
| 87040 | 4,663 | 4,291 | $2K | |
| 10061 | 12 | 12 | $2K | |
| 84154 | 192 | 190 | $2K | |
| 86300 | 115 | 108 | $2K | |
| 82164 | 289 | 283 | $2K | |
| 86162 | 159 | 158 | $2K | |
| 86922 | 654 | 534 | $2K | |
| 92025 | 332 | 332 | $2K | |
| 73620 | 428 | 413 | $2K | |
| 95812 | 12 | 12 | $2K | |
| 86356 | 231 | 229 | $2K | |
| 86308 | 2,224 | 2,203 | $2K | |
| 86336 | 267 | 267 | $2K | |
| 85018 | 6,353 | 5,768 | $2K | |
| G0008 | Administration of influenza virus vaccine | 356 | 355 | $2K |
| 96127 | 187 | 187 | $2K | |
| 86812 | 118 | 117 | $2K | |
| 91322 | 15 | 15 | $2K | |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | 103 | 100 | $2K |
| 93298 | 104 | 103 | $2K | |
| P9047 | Infusion, albumin (human), 25%, 50 ml | 21 | 12 | $2K |
| 82787 | 111 | 110 | $2K | |
| 85014 | 4,963 | 4,528 | $2K | |
| 83498 | 183 | 182 | $2K | |
| 73565 | 4,764 | 4,733 | $2K | |
| 92524 | 37 | 36 | $2K | |
| 93797 | 23 | 13 | $2K | |
| 90473 | 131 | 131 | $2K | |
| 90739 | 12 | 12 | $2K | |
| 43762 | 12 | 12 | $1K | |
| 88173 | 432 | 426 | $1K | |
| 93297 | 99 | 99 | $1K | |
| 96450 | 13 | 12 | $1K | |
| 82140 | 383 | 351 | $1K | |
| 84300 | 1,018 | 976 | $1K | |
| 83605 | 7,602 | 6,814 | $1K | |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 1,120 | 1,097 | $1K |
| 72131 | 37 | 37 | $1K | |
| 83722 | 125 | 124 | $1K | |
| 90647 | 2,393 | 2,390 | $1K | |
| 73521 | 55 | 55 | $1K | |
| 87581 | 138 | 137 | $1K | |
| 76886 | 28 | 28 | $1K | |
| 59426 | 75 | 73 | $1K | |
| 86005 | 126 | 123 | $1K | |
| 76821 | 629 | 330 | $1K | |
| 87486 | 135 | 134 | $1K | |
| 86060 | 263 | 261 | $1K | |
| 77370 | 26 | 25 | $1K | |
| 87184 | 295 | 293 | $1K | |
| 92250 | 205 | 203 | $1K | |
| 84145 | 2,695 | 2,615 | $1K | |
| 87541 | 118 | 117 | $1K | |
| 84681 | 92 | 92 | $1K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 57 | 57 | $1K |
| 93925 | 12 | 12 | $1K | |
| 88262 | 26 | 25 | $1K | |
| 85660 | 458 | 435 | $1K | |
| 83014 | 195 | 194 | $1K | |
| 76813 | 102 | 101 | $1K | |
| 73120 | 162 | 155 | $1K | |
| 57454 | 12 | 12 | $1K | |
| C1769 | Guide wire | 4,081 | 3,902 | $997.75 |
| 86645 | 99 | 98 | $977.88 | |
| 92567 | 3,089 | 3,071 | $968.75 | |
| 14040 | 12 | 12 | $963.03 | |
| 80178 | 309 | 280 | $955.19 | |
| G0109 | Diabetes outpatient self-management training services, group session (2 or more), per 30 minutes | 22 | 14 | $901.33 |
| 99382 | 14 | 14 | $880.27 | |
| 82952 | 378 | 377 | $866.45 | |
| 83930 | 1,038 | 983 | $809.58 | |
| 70480 | 13 | 13 | $805.38 | |
| 83520 | 539 | 525 | $786.04 | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 2,651 | 2,620 | $771.54 |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 8,431 | 5,945 | $759.87 |
| 86905 | 16 | 15 | $755.20 | |
| 84703 | 3,683 | 3,592 | $749.34 | |
| 88312 | 244 | 239 | $747.39 | |
| 84295 | 1,289 | 1,256 | $739.65 | |
| 83718 | 148 | 146 | $734.59 | |
| 85045 | 333 | 333 | $729.56 | |
| 96415 | 15 | 13 | $715.69 | |
| 12001 | 401 | 397 | $706.80 | |
| 86593 | 264 | 263 | $700.52 | |
| 0173A | 17 | 17 | $662.89 | |
| 85384 | 266 | 250 | $620.69 | |
| 80202 | 124 | 75 | $592.62 | |
| 90685 | 754 | 748 | $586.35 | |
| 83695 | 72 | 71 | $580.46 | |
| 82945 | 470 | 467 | $553.46 | |
| 84157 | 461 | 455 | $530.41 | |
| 85245 | 46 | 40 | $525.58 | |
| 73600 | 286 | 270 | $517.41 | |
| 86340 | 47 | 46 | $484.67 | |
| 85240 | 50 | 44 | $474.58 | |
| 85303 | 68 | 67 | $469.21 | |
| 82010 | 1,908 | 1,708 | $467.11 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 2,386 | 2,360 | $464.99 |
| 87015 | 348 | 329 | $456.11 | |
| 90658 | 26 | 26 | $444.42 | |
| 96381 | 29 | 29 | $435.51 | |
| 0071A | 12 | 12 | $427.61 | |
| 82575 | 135 | 132 | $415.21 | |
| 90633 | 2,300 | 2,295 | $414.66 | |
| 93976 | 12 | 12 | $407.82 | |
| 85306 | 51 | 51 | $405.59 | |
| 82668 | 38 | 38 | $402.27 | |
| 82435 | 230 | 230 | $394.15 | |
| C1889 | Implantable/insertable device, not otherwise classified | 1,808 | 1,778 | $386.00 |
| 94644 | 68 | 67 | $386.00 | |
| 83630 | 38 | 37 | $385.53 | |
| 87109 | 40 | 40 | $369.74 | |
| 94760 | 2,844 | 2,510 | $360.85 | |
| 64447 | 39 | 39 | $360.42 | |
| 0124A | 12 | 12 | $359.82 | |
| 85244 | 34 | 28 | $350.79 | |
| 82626 | 24 | 24 | $345.32 | |
| 85300 | 52 | 52 | $341.72 | |
| 82340 | 110 | 107 | $339.19 | |
| 94664 | 26 | 26 | $336.90 | |
| 86705 | 56 | 56 | $313.65 | |
| 86357 | 13 | 13 | $313.25 | |
| 86355 | 13 | 13 | $313.25 | |
| 82374 | 109 | 109 | $305.51 | |
| 88720 | 155 | 102 | $299.77 | |
| 97022 | 40 | 12 | $278.00 | |
| 82955 | 49 | 49 | $276.67 | |
| 86747 | 13 | 13 | $244.19 | |
| J2785 | Injection, regadenoson, 0.1 mg | 1,798 | 1,778 | $235.54 |
| 93280 | 32 | 31 | $231.44 | |
| 12011 | 328 | 325 | $227.61 | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 2,849 | 2,623 | $225.75 |
| 83835 | 26 | 24 | $221.28 | |
| J1644 | Injection, heparin sodium, per 1000 units | 19,959 | 9,216 | $219.32 |
| J0690 | Injection, cefazolin sodium, 500 mg | 12,658 | 10,531 | $213.60 |
| 58300 | 12 | 12 | $209.76 | |
| 82542 | 180 | 180 | $209.76 | |
| 86317 | 28 | 12 | $209.01 | |
| 84163 | 38 | 38 | $206.76 | |
| 86702 | 24 | 24 | $201.80 | |
| 84133 | 164 | 157 | $193.15 | |
| 36000 | 44 | 44 | $193.00 | |
| 80175 | 52 | 48 | $188.56 | |
| 85007 | 93 | 91 | $185.39 | |
| 87076 | 54 | 54 | $173.22 | |
| 85613 | 38 | 38 | $172.40 | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 2,654 | 2,314 | $160.39 |
| 82077 | 614 | 563 | $150.19 | |
| 87210 | 4,104 | 3,958 | $145.78 | |
| 85597 | 14 | 14 | $141.48 | |
| 86701 | 25 | 25 | $139.96 | |
| 84080 | 12 | 12 | $121.17 | |
| 76827 | 761 | 728 | $117.57 | |
| 73522 | 13 | 13 | $114.60 | |
| 97012 | 40 | 12 | $114.55 | |
| 84590 | 14 | 14 | $104.38 | |
| 87341 | 16 | 16 | $102.03 | |
| 87808 | 2,246 | 2,207 | $101.39 | |
| 82365 | 79 | 78 | $99.60 | |
| 99358 | Prolong nursin fac eval 15m | 431 | 411 | $99.00 |
| 86709 | 15 | 15 | $89.23 | |
| 90723 | 2,391 | 2,389 | $82.64 | |
| 93242 | 12 | 12 | $81.78 | |
| 84255 | 12 | 12 | $79.35 | |
| 36591 | 13 | 12 | $66.58 | |
| 99177 | 181 | 181 | $66.50 | |
| 87493 | 13 | 13 | $66.15 | |
| 86902 | 28 | 25 | $63.88 | |
| 69210 | 28 | 27 | $63.76 | |
| 77073 | 12 | 12 | $57.04 | |
| 88311 | 142 | 137 | $56.78 | |
| 92136 | 12 | 12 | $55.61 | |
| 82948 | 258 | 249 | $55.61 | |
| 90662 | 15 | 15 | $53.37 | |
| 90715 | 4,801 | 4,779 | $48.75 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 53,031 | 43,376 | $48.40 |
| 88302 | 42 | 39 | $43.93 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 42,309 | 37,409 | $38.87 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 35,885 | 30,620 | $33.61 |
| 85347 | 1,089 | 1,021 | $33.40 | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 8,695 | 8,474 | $33.35 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 1,084 | 1,066 | $31.84 |
| J1170 | Injection, hydromorphone, up to 4 mg | 21,051 | 13,342 | $29.66 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 26,778 | 25,226 | $18.40 |
| J2704 | Injection, propofol, 10 mg | 32,732 | 31,143 | $18.09 |
| 81000 | 15 | 15 | $16.77 | |
| 86880 | 24 | 24 | $16.28 | |
| 83935 | 14 | 13 | $13.19 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 7,269 | 5,650 | $12.88 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 183 | 165 | $12.12 |
| J7030 | Infusion, normal saline solution , 1000 cc | 2,458 | 2,111 | $10.98 |
| J0134 | Injection, acetaminophen (fresenius kabi), not therapeutically equivalent to j0131, 10 mg | 855 | 808 | $10.53 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 7,890 | 5,814 | $10.17 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 34,582 | 27,737 | $9.07 |
| J3370 | Injection, vancomycin hcl, 500 mg | 3,479 | 2,088 | $9.06 |
| 82800 | 297 | 281 | $8.39 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 26,756 | 24,872 | $7.95 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 2,845 | 1,148 | $7.83 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 6,158 | 6,022 | $7.10 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 2,861 | 2,376 | $6.72 |
| 99188 | 48 | 48 | $6.48 | |
| J0736 | Injection, clindamycin phosphate, 300 mg | 200 | 163 | $5.60 |
| J1940 | Injection, furosemide, up to 20 mg | 645 | 370 | $4.89 |
| C9113 | Injection, pantoprazole sodium, per vial | 4,511 | 2,194 | $4.28 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 4,773 | 4,210 | $3.19 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 2,784 | 1,626 | $2.05 |
| J2060 | Injection, lorazepam, 2 mg | 7,542 | 4,617 | $1.95 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 7,382 | 6,639 | $1.44 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 14,828 | 12,753 | $1.21 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 27 | 25 | $0.24 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 457 | 430 | $0.24 |
| 90696 | 445 | 444 | $0.02 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 256 | 227 | $0.02 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 1,080 | 1,051 | $0.02 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 203 | 189 | $0.02 |
| 90680 | 3,381 | 3,379 | $0.01 | |
| G8980 | Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting | 115 | 110 | $0.01 |
| G1004 | Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program | 2,058 | 1,947 | $0.01 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 2,908 | 2,845 | $0.01 |
| J3480 | Injection, potassium chloride, per 2 meq | 1,572 | 1,101 | $0.00 |
| J0461 | Injection, atropine sulfate, 0.01 mg | 1,219 | 1,180 | $0.00 |
| 95886 | 1,328 | 1,323 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 3,005 | 2,953 | $0.00 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | 858 | 841 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 1,773 | 1,754 | $0.00 |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 2,670 | 1,681 | $0.00 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 6,028 | 3,830 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 764 | 595 | $0.00 |
| A9270 | Non-covered item or service | 4,313 | 565 | $0.00 |
| 93320 | 1,910 | 1,874 | $0.00 | |
| 90632 | 338 | 336 | $0.00 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 1,829 | 821 | $0.00 |
| 90698 | 1,384 | 1,383 | $0.00 | |
| A4648 | Tissue marker, implantable, any type, each | 1,145 | 1,114 | $0.00 |
| G8988 | Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 46 | 43 | $0.00 |
| 97010 | 93 | 52 | $0.00 | |
| J1630 | Injection, haloperidol, up to 5 mg | 3,207 | 2,333 | $0.00 |
| J2790 | Injection, rho d immune globulin, human, full dose, 300 micrograms (1500 i.u.) | 96 | 88 | $0.00 |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | 142 | 96 | $0.00 |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | 225 | 75 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 854 | 615 | $0.00 |
| J3411 | Injection, thiamine hcl, 100 mg | 1,458 | 720 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 981 | 824 | $0.00 |
| J3360 | Injection, diazepam, up to 5 mg | 90 | 81 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 636 | 351 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 341 | 226 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 87 | 86 | $0.00 |
| 74420 | 113 | 108 | $0.00 | |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 63 | 63 | $0.00 |
| 84270 | 799 | 782 | $0.00 | |
| J1836 | Injection, metronidazole, 10 mg | 23 | 14 | $0.00 |
| 94761 | 193 | 171 | $0.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 96 | 94 | $0.00 |
| J3490 | Unclassified drugs | 4,505 | 4,359 | $0.00 |
| 80320 | 117 | 105 | $0.00 | |
| J7999 | Compounded drug, not otherwise classified | 361 | 324 | $0.00 |
| C2617 | Stent, non-coronary, temporary, without delivery system | 444 | 419 | $0.00 |
| 91305 | 28 | 28 | $0.00 | |
| J0280 | Injection, aminophyllin, up to 250 mg | 82 | 82 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 126 | 120 | $0.00 |
| 51600 | 105 | 104 | $0.00 | |
| J2470 | Injection, pantoprazole sodium, 40 mg | 231 | 149 | $0.00 |
| G8987 | Self care functional limitation, current status, at therapy episode outset and at reporting intervals | 32 | 31 | $0.00 |
| A9573 | Injection, gadopiclenol, 1 ml | 461 | 451 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 65 | 65 | $0.00 |
| 36410 | 27 | 24 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 95 | 67 | $0.00 |
| C1781 | Mesh (implantable) | 26 | 25 | $0.00 |
| 90619 | 41 | 41 | $0.00 | |
| 29826 | 12 | 12 | $0.00 | |
| 91317 | 17 | 17 | $0.00 | |
| J8501 | Aprepitant, oral, 5 mg | 14 | 14 | $0.00 |
| 77417 | 19 | 15 | $0.00 | |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 12 | 12 | $0.00 |
| 83883 | 46 | 46 | $0.00 | |
| J7121 | 5% dextrose in lactated ringers infusion, up to 1000 cc | 52 | 40 | $0.00 |
| 91307 | 15 | 12 | $0.00 | |
| L8699 | Prosthetic implant, not otherwise specified | 15 | 15 | $0.00 |
| 94618 | 13 | 13 | $0.00 | |
| 58340 | 16 | 16 | $0.00 | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 3,062 | 2,924 | $0.00 |
| 94729 | 1,768 | 1,766 | $0.00 | |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 1,511 | 1,487 | $0.00 |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 279 | 279 | $0.00 |
| 76937 | 247 | 240 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,997 | 1,737 | $0.00 |
| C1776 | Joint device (implantable) | 483 | 480 | $0.00 |
| 93325 | 3,706 | 3,598 | $0.00 | |
| C1729 | Catheter, drainage | 423 | 290 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 345 | 342 | $0.00 |
| 77002 | 170 | 169 | $0.00 | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 3,852 | 3,309 | $0.00 |
| 76942 | 1,760 | 1,715 | $0.00 | |
| J1580 | Injection, garamycin, gentamicin, up to 80 mg | 224 | 209 | $0.00 |
| 80143 | 204 | 197 | $0.00 | |
| 99354 | 101 | 99 | $0.00 | |
| J2800 | Injection, methocarbamol, up to 10 ml | 882 | 520 | $0.00 |
| C1762 | Connective tissue, human (includes fascia lata) | 125 | 122 | $0.00 |
| 82610 | 221 | 208 | $0.00 | |
| J0735 | Injection, clonidine hydrochloride, 1 mg | 664 | 653 | $0.00 |
| C1758 | Catheter, ureteral | 66 | 65 | $0.00 |
| 90707 | 605 | 605 | $0.00 | |
| J1650 | Injection, enoxaparin sodium, 10 mg | 1,997 | 859 | $0.00 |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 1,526 | 1,513 | $0.00 |
| 90700 | 572 | 571 | $0.00 | |
| 95957 | 385 | 270 | $0.00 | |
| C8937 | Computer-aided detection, including computer algorithm analysis of breast mri image data for lesion detection/characterization, pharmacokinetic analysis, with further physician review for interpretation (list separately in addition to code for primary procedure) | 26 | 26 | $0.00 |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 664 | 624 | $0.00 |
| Q9958 | High osmolar contrast material, up to 149 mg/ml iodine concentration, per ml | 96 | 95 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 298 | 223 | $0.00 |
| C1760 | Closure device, vascular (implantable/insertable) | 110 | 105 | $0.00 |
| C1780 | Lens, intraocular (new technology) | 87 | 83 | $0.00 |
| 76125 | 149 | 146 | $0.00 | |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 360 | 213 | $0.00 |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 43 | 26 | $0.00 |
| 76001 | 84 | 83 | $0.00 | |
| 80179 | 193 | 187 | $0.00 | |
| 99152 | 71 | 71 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 418 | 289 | $0.00 |
| 90648 | 12 | 12 | $0.00 | |
| A9537 | Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 25 | 25 | $0.00 |
| J1953 | Injection, levetiracetam, 10 mg | 30 | 25 | $0.00 |
| 95251 | 14 | 14 | $0.00 | |
| 90461 | 61 | 61 | $0.00 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 115 | 111 | $0.00 |
| C1788 | Port, indwelling (implantable) | 12 | 12 | $0.00 |
| 91312 | 12 | 12 | $0.00 | |
| 93321 | 46 | 45 | $0.00 | |
| 77387 | 319 | 30 | $0.00 | |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 25 | 25 | $0.00 |
| 82731 | 12 | 12 | $0.00 | |
| 77003 | 13 | 12 | $0.00 | |
| 90710 | 19 | 19 | $0.00 | |
| G8989 | Self care functional limitation, discharge status, at discharge from therapy or to end reporting | 14 | 14 | $0.00 |